Table 2 Micro-CT assessment of trabecular bone region at the distal femur and cortical bone region at the femoral midshaft.
Variables | Week 3 | Week 6 | Week 9 | |||
---|---|---|---|---|---|---|
Vehicle | Scl-Ab | Vehicle | Scl-Ab | Vehicle | Scl-Ab | |
Distal femur - Trabecular region | ||||||
BV/TV | 0.07 ± 0.04 | 0.08 ± 0.02 | 0.07 ± 0.03 | 0.20 ± 0.03** | 0.09 ± 0.03 | 0.39 ± 0.06** |
BMD (mg HA/cm3) | 708 ± 36 | 726.3 ± 23.4 | 704 ± 16 | 760 ± 10** | 721 ± 16 | 804 ± 10** |
BMC (mg HA) | 1,677 ± 864 | 2,008 ± 677 | 1,528 ± 644 | 5,081 ± 1,167** | 2,187 ± 657 | 11,461 ± 2,895** |
Tb.N (1/mm) | 1.07 ± 0.27 | 1.11 ± 0.26 | 1.00 ± 0.32 | 1.80 ± 0.30** | 1.37 ± 0.28 | 2.16 ± 0.18** |
Tb.Th (mm) | 0.05 ± 0.01 | 0.07 ± 0.01* | 0.06 ± 0.01 | 0.11 ± 0.01** | 0.06 ± 0.01 | 0.18 ± 0.03** |
Tb.Sp (mm) | 0.88 ± 0.36 | 0.88 ± 0.25 | 1.03 ± 0.33 | 0.46 ± 0.09** | 0.69 ± 0.16 | 0.28 ± 0.04* |
Femoral midshaft - Cortical region | ||||||
BMD (mg HA/cm3) | 907 ± 25 | 924 ± 22 | 921 ± 29 | 967 ± 19 | 988 ± 24 | 970 ± 16 |
BMC (mg HA) | 29,583 ± 2,143 | 31,525 ± 2,852 | 30,404 ± 3,244 | 36,679 ± 3,095** | 32,954 ± 1,675 | 38,839 ± 3,117** |
CSA (mm2) | 8.67 ± 0.55 | 9.07 ± 0.70 | 8.77 ± 0.86 | 10.07 ± 0.69** | 8.86 ± 0.32 | 10.64 ± 0.85** |
Ct.Th (mm) | 0.67 ± 0.03 | 0.68 ± 0.05 | 0.67 ± 0.05 | 0.77 ± 0.04** | 0.70 ± 0.05 | 0.86 ± 0.04** |
CSMI (mm4) | 33.5 ± 4.4 | 36.1 ± 6.1 | 34.3 ± 5.3 | 39.0 ± 6.1 | 32.3 ± 3.1 | 39.6 ± 7.0* |
BSICSA | 7,864 ± 570 | 8,380 ± 758 | 8,082 ± 862 | 9,750 ± 823** | 8,760 ± 445 | 10,324 ± 829** |
BSICSMI | 30,368 ± 4,224 | 33,384 ± 6,056 | 31,615 ± 5,192 | 37,794 ± 6,328* | 31,900 ± 2,960 | 38,053 ± 6,414* |